Nov 19

GQ isn’t part of my staple reading diet, but every so often my personalized Google News feed pulls in a great story loaded with actionable insights. Last month, it was an article on the breakout of personal genomics, entitled, “The Book of Me.”

Today GQ published an article online on  four-star General David Petraeus, entitled, “Leader of the Year.” A key graph:

He starts by talking about his father, Sixtus Petraeus, who passed away six months ago at the age of 92. Petraeus couldn’t even leave Iraq to bury him. (As he puts it, “Our soldiers make all the same sacrifices.”) Sixtus was a Dutch sea captain who came to the U.S. at the start of World War II, “when Holland was overrun. He was at sea, and they couldn’t go back to Rotterdam, so they went to New York.” He was “a stubborn, independent Dutchman” who was both extraordinarily proud of his only son and a strict disciplinarian who pushed him to the limit. “I was raised by the kind of father who if his son could do twenty pull-ups, he wanted you to do twenty-one. There were, you know, no excuses. I mean, there was a phrase he actually used: Results, boy.’ ” 

Later on in the article, writer Lisa DePaulo notes that the patterns of change experimented with and refined to success by Petraeus when he was running the 101 Airborne Division in Mosul in 2003, did not come from the top of the “theatre” or Pentagon command structure. They came from “the fringe,” or as Petraeus says:

“Well, I would sort of think it was intuitively obvious. To be truthful…strategic leaders make big decisions at times. And at my level, in the first year and very early on, a huge decision was to say, ‘We are going to do nation building.’ I know that we as a country didn’t think the military should get into nation building and all this. But very early on, we decided in the 101st that we’re gonna do it…” 

Those who have followed the Iraq war in depth — and not just through the superficial coverage in most of the press — will know that Petraeus was not popular with his “uplines” in the command structure for his views or for the successes he achieved in Mosul, even though he did it without “glory-seeking” or challenging the chain of command. ** 

After his outstandingly successful Mosul tour of duty was up, Petraeus was transferred by his superiors in the Pentagon command structure, back to a desk job for awhile (where he wrote a new Army field manual on counterinsurgency strategy), before being plucked out by President Bush to turn the war around.

That’s an oversimplified and truncated version of events, but the point is that Petraeus didn’t wait for those “smarter” than him, “more experienced” than him in the “same old same old” to tell him what to do, within his legitimate sphere of decision making and action taking.

As an aside, if you enjoy romances, writer Lisa DePaulo humorously shares how Petraeus met and courted his wife. DePaulo notes with supreme deadpan:

Perhaps the “wildest” thing was when he [young cadet Petraeus] ended up dating the daughter of the superintendent (who also happened to be a three-star, soon to be four-star general named William Knowlton) of West Point. Or “the Supe’s daughter,” as she was known. Knowlton was a man you didn’t want to mess with… 

SPEAKING OF AMWAY GLOBAL, have you thought about how real change — and as Petraeus puts it, “irreversible success,” — is going to come to your business? As Bridgett put it in a comment at IBOFB’s Amway Talk blog a couple days ago, change always happens at the fringes first.

** disclosure: one of my cousins served with the 101 Airborne in Mosul as an army doc for two years, which has added to the respect I have for Petraeus’ approach to modeling personal leadership and responsibility.

written by rdknyvr \\ tags: , , , , , , , , , , ,

Nov 11

Fortune Magazine, in an article published online Nov. 10, has yet again provided a fascinating insight into why Apple is both the ‘Most Admired Company’ in North America (if not the world), and perhaps the best run company too. Much of the public credit goes to iconic founder and “reinventor” Steve Jobs. But this article reveals one of Job’s less-remarked-on skills — the ability to develop a deep bench of executive talent to support and extend the ‘Apple Vision’.

Fortune’s Phillip Elmer-Dewitt writes at his Apple 2.0 blog — quoting from the ChangeWave Research Report released yesterday:

“It’s not easy to increase market share in one of the worst spending environments in years,” writes Carton, but Apple seems poised to do so. Among those few consumers who plan to buy a laptop in the next three months, one-third said they planned to buy an Apple — up from 29% in September.

As Amway Global prepares to wrap up another financial year and evaluates the success, thus far, of its Transformation game plan, what core goal could it set to ensure future leadership, not just in the direct sales “industry” but in a way that would empower it to stand along side industry giants in the Fortune ‘Most Admired’ list of companies. 

Remember that it was only 10 or so years ago when Apple was languishing – it stock had become a ‘laughing stock’ (before Jobs returned). Michael Dell infamously recommended that the best thing that could be done with Apple would be to liquidate it and return the remaining scraps of value to the shareholders.

Today, Apple has been surging with record-breaking growth, profits and good will while at the same time adjusting and fine-tuning price points on the strategic Macbook, iPhone and iPod lines — even while continuing to ‘add value’ to those products, and ‘build out’ from the base of raving fans (to borrow from the Ken Blanchard title) created on its common platform of iPod, iPhone, Macbook and worlds’ most customer-friendly software interface.

SPEAKING OF AMWAY, is Amway Global the kind of enterprise which should aspire to being mentioned with respect and admiration (and, by its IBOs, with pride) in the same breath as Apple, Google, Goldman Sachs, Johnson & Johnson, Berkshire Hathaway, or Toyota?

Could Amway Global — and that includes independent business owners — pull off its own ”Cinderella story“?

Well, why not? 

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , , ,

Nov 03

Seth Godin has made the audio of his recent book Tribes available for FREE. Interesting marketing strategy given that the hardcover edition was published only two weeks ago on Oct. 16. Lots of content in the audio that is highly applicable to our business development model. IBOFightBack, over at The Truth About Amway, has the details here. Or you can go directly to the special promo at Audible.com and download directly.

written by rdknyvr \\ tags: , , , , , ,

Nov 03

One of my favorite blogs — GigaOM — posted a story recently about Paul Polak, a successful life-long entrepreneur. Polak started his first business at age 15, and is still starting, funding and incubating new businesses at the agile age of 75. Complete article here. Polak ascribes much of his business success to the following 12 principles, described more fully in his recent book, Out of Poverty: What Works When Traditional Approaches Fail.

SPEAKING OF AMWAY, which ones do you identify with, and which ones could you adopt, adapt or modify to help your business become more successful? Not your upline or sponsor’s business. Not Alticor or Amway Global’s business. YOUR business.

 The 12 Steps to Practical Problem Solving:

1. Go where the action is. “Spend significant time with your customers. This is how you learn what they need,” he says. Not hours, days. Polak lived with his farmers for 6 months.

2. Interview at least 100 customers a year. You do it. Not an employee. Listen to what they have to say. “Too many entrepreneurs build the product they want to build — not the one that’s needed.”

3. Context matters. If your solution isn’t right for the context, for example, if it costs too much for the customers you’re trying to serve, you won’t succeed.

4. Think big. Act big. 

5. Think like a child.

6. See and do the obvious. Others won’t, which is opportunity for you.

7. Leverage precedents. If somebody has already invented it, don’t do it again.

8. Scale. Your business must have potential to scale. Remember, your market must include at least 1 million customers.

9. Design to specific cost and price targets. Not the other way around. (Celeste: it means — Do not price to your design, design to the price you need to hit to make your product appropriate to your customer.).

10. Follow practical three-year plans. Two years is too short. Ten is too long.

11. Visit your customers again. And again. “Any successful business in this country is based on talking to your customers all the time. A good CEO spends half his time ‘in the field.’”

12. Stay positive. Don’t be distracted by what other people think. 

written by rdknyvr \\ tags: , , , , ,

Oct 28

Buried at the end of the last post — on the GQ magazine story related to Personalized Health — was a jewel of a link to a quick, four-minute streaming video from the Interleukin Genetics site. It’s simply titled, The Science Behind Interleukin Genetics

If you’ve ever pondered over how to explain to a retail customer (or a potential business associate) what the Gensona DNA tests are about and the life-long value of the information they provide, now you don’t (have to ponder). Just refer your retail customer or potential business associate to this link for a quick, easy-to-understand presentation.

The Science Behind Interleukin Genetics

****************

Still with me? Attention span longer than you  thought? (hehe) 

Beyond that, you should still know something about the Nutrilite brand and why it gives us such a unique position in the marketplace. If you don’t know how to talk about Nutrilite’s history and the just-in-time fresh fresh freshness of the organic functional-whole-food-based products you represent, here are a few more “movies” to which you can go (and take your retail customer along).

Washington State organic farm

Mexico organic farm

Brazil organic farm

Optimal Health: The Heart of the Original Brand

Lifestyle

Personalization

Nutrigenomics

Nutrilite clinical validation studies

Nutrilite research associations

SPEAKING OF AMWAY, don’t foget to watch this space for a timely and provocative three-part series coming very soon from the pen keyboard of Chuck Lia.

Blessings for a great day… :)

written by rdknyvr \\ tags: , , , , , , , , , ,

Oct 24

NOTE TO READERS: text below in bold and blue is hotlinked to additional background info.  

This new article in GQ Magazine, The Book of Me, is of keen interest in that it demonstrates how personal genomics and Personalized Health are now growing in mass market interest in general media outlets, and not just science-oriented journalism and publications.Someone in the Alticor organization had the exceptional foresight back around 2002 or 2003 to recommend an ‘angel investment’ in Interleukin Genetics, which had made some key discoveries — pre-Human Genome Project completion — which are turning out to be core to understanding how our personal genetics influences the ageing process and chronic health conditions related thereto. Interleukin was able to apply for a number of patents based on their unique discoveries and thus claim some significant IP real estate in the “land rush” around human genome research which is shaping the future of health and health care. Alticor has thus far shown good patience with their investment in Interleukin and has provided its Distributors with an unparalleled product and business development opportunity with the Gensona DNA tests, and Nutrilite’s IL-1 Heart Health supplement — the world’s first clinically validated (published in peer-reviewed and respected scientific journals) nutrigenomic supplement – with more in the Nutrilite and Interleukin research pipelines. The article in GQ is an easy read and well-written, almost in a mystery novel genre by a top-selling novelist, so your time spent reading will be enjoyable for those who don’t think they “like” science related stuff, and a joy for those of us who see the future now and can’t wait.A key quote from the article — key for me, at least: 

He [George Church, Harvard University] defends the coming revolution, comparing it to the birth of personal computing in the late 1970s. That earlier revolution was all about mass empowerment, going, he says, “from a few people in the priesthood that guarded the mainframes, to everybody.” But few people saw the potential of that revolution early on: “Just like with personal computing, until there are some compelling stories involving real products [my emphasis] the only people who are going to get what’s happening are the ones who can imagine things that aren’t yet there.”                                        

 SPEAKING OF AMWAY GLOBAL, where do you rank Personalized Health and Nutrilite Health in your list of business development priorities? Is it “hot” or is it “not” for you, and why? Second, what is Amway Global doing well to assist you in understanding and marketing the Gensona DNA tests and the Nutrilite IL-1 Heart Health, and what in your view might they do better?  Before you answer that last question, watch this video clip

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , , ,

Sep 12

For those of us focusing on the Personalized Health opportunity, the following excerpt from a press release this morning definitely adds a spring to our step (see quoted section below).

 With Personalized Health — which includes Interleukin Genetics’s patent protected IP and DNA tests, which we market under the Gensona brand, and the IL-1 Heart Health supplement patented by Nutrilitewe truly have an opportunity to reshape the health care debate in North America, even more so than the politicians campaigning for election at this moment in both the US and Canada.

As of next year, 2009, that same Personalized Health opportunity will be available to our colleagues in Asia as well, when Gensona DNA tests are rolled out for markets there.

Paper Reports Value of Specific Nutritional Products is Dependent on Individual’s Genetic Make-up WALTHAM, Mass., Sept. 12

WALTHAM, Mass., Sept. 12 /PRNewswire-FirstCall/ — Researchers at
Interleukin Genetics, Inc. (Amex: ILI), today received the 12th John M. Kinney Award for Nutrition and Metabolism at the annual Congress of the European Society of Parenteral and Enteral Nutrition, in Florence, Italy. The award was given for the paper, “Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept,” which was published in Nutrition: The International Journal of Applied and Basic Nutritional Sciences (2007;23:844-852).

Kenneth Kornman, Ph.D., Chief Scientific Officer at Interleukin Genetics, and the first author on the publication, commented, “We are honored to receive the 12th

John M. Kinney Award for Nutrition and Metabolism. Many botanical and nutritional supplements claim to provide countless health benefits without being subjected to rigorous clinical study. Our paper reports a well- controlled clinical study has shown the value of specific nutritional products is dependent on an individual’s genetic make-up.” The study, a joint research effort by scientists at Interleukin Genetics and Nutrilite, a division of Alticor Inc., is one of the few controlled clinical trials that has shown the value of specific nutritional products is dependent on an individual’s genetic make-up. The data showed that a proprietary botanical supplement (Nutrilite IL1 Heart Health Supplement) could lower inflammation in individuals who tested positive for pro-inflammatory IL-1 gene variations from Interleukin Genetics’ Heart Health Genetic Test. These individuals also had elevated levels of C-reactive protein.

About Interleukin Genetics’ Heart Health Genetic Test

Interleukin Genetics’ Heart Health Genetic Test was developed to identify healthy individuals who are genetically predisposed to over-produce inflammation and are at an increased risk for an early first heart attack.

The Heart Health Genetic Test is marketed on a non-exclusive basis [edit: it became non-exclusive for us only as of last week] through Access Business Group International LLC, a division of Alticor Inc. Interleukin Genetics recently announced an agreement with Access Business Group International that will permit the expansion of Interleukin Genetics’ distribution network for such genetic tests.

About Nutrilite IL1 Heart Health Supplement

Nutrilite IL1 Heart Health Supplement, a proprietary botanical supplement, was developed to reduce inflammation in those individuals who are genetic over-producers. The Nutrilite IL1 Heart Health Supplement is currently marketed by Quixtar, Inc., a division of Alticor Inc.

About Interleukin Genetics

Interleukin Genetics, Inc. (Amex: ILI), is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics currently offers an array of Nutraceuticals and OTCeuticals(R), which are sold at the nation’s largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment.

Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics, its products and ongoing programs, please visit
www.ilgenetics.com.

Note, of course, that as of last week, Amway Global business owners no longer have the exclusive distribution rights to the Interleukin DNA test IP. Why? Two basic reasons:

(1) Because of Quixtar’ screwed up launch and lack of support for  the Personalized Health product portfolio and health solution two-plus years ago and ongoing. They admitted as much when management acknowledged last year that Personalized Health was the victim of a “launch and abandon” product support mentality that prevailed before Steve Liebeman came on board and took control.

(2) In the old (and growth-destroying) business model — still ‘de facto’ business practice for most – based on the “Systems”-developed and promoted ”buy from yourself and teach others to do the same,” a major product/solution portfolio like Personalized Health was doomed to fail on that count as well. This could just as well be characterized as a “lack of leadership” by organizations which claim to be devoted to teaching leadership principles.

The defining advantage Independent Business Owners still have with Personalized Health is the core “value-add proposition” which we bring to the table — the ability to educate the consumer in a field which requires consumer education to be successful. Under the new retail sales focused paradigm being driven, thankfully, by Steve Lieberman and his new team, Personalized Health finally has an opportunity to flourish, and be the breakout health solution which will take Amway Global in North America way beyond the goals set by Doug DeVos and Steve Van Andel.

 I’m driving down to Portland later today to the Spotlight showcase, and hopefully Personalized Health and Amway Wellness will be getting the “showcase profile” they deserve. With Interleukin Genetics now winning these kinds of international awards for their ground-breaking research, we expect to see Personalized Health being promoted and celebrated front and center.

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , , , , , ,

Aug 05

 One more quick post before Chuck puts up the thought provoker he’s been working on!!!

Note that blue text contains a fascinating URL link which you should click on for background info; red text is for emphasis/highlight only.

I’ve recently come across a series of insightful articles about the growth potential for Online Health, and recommend you too check out Sramana Mitra’s excellent blog, Sramana Mitra On Strategy, specifically the 5 article series Web 3.0 and Online Health.

One of the reasons Sramana’s analysis is so important relates to our Online Personalized Health Questionnaire.  This to me is the KEY VALUE ADD piece to the whole Personalized Health value proposition… and critical to supporting sales of the Interleukin Genetics Gensona DNA tests and Nutrilite’s consumable supplements such as Double X and the IL-1 Heart Health Nutrigenomic supplement, and so on.

The online Personalized Health Questionnaire is confidential, it’s free, and via the recommendations made based on the Gensona tests and the lifestyle and health question modules, provides the critical link between the DNA tests, and the appropriate Nutrilite products and lifestyle and diet and behaviour modification recommendations.

The other critical differentiator for Personalized Health in the online health channel/business space, which we have and no one else does, is our direct sales business model with its emphasis on education of the consumer and each business person building a base of retail customers.

And that is why Alticor’s Transformation process is precisely what is needed in order for the company and us to surge over the next couple of years.

But the Personalized Health Questionnaire and our direct sales business model ARE the key differentiators for success against all potential competitors, including ‘23andme‘, Navigenics, DeCodeMe, and a host of other startups and wanna-be’s.

By the way, if you enjoy Sramana’s writing style as much as I do, here’s another wonderful series she has written on the “modernization” of Indian architechureAs India Builds. Her whole series on India will be of interest to any readers from India or desi backgrounds, or any who are as fascinated with that country of contrasts as I am.

Enjoy!

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , ,

Jul 29

Just in case there are any genuinely committed business builders reading this blog who are building an Amway Wellness (ie. Nutrilite, Gensona, etc.), or an Amway Beauty business (which could include relevant Gensona tests at some point) this brief post will draw your attention to an interesting blog on personal genomicsgenomeboy — and an excellent new article in Wired magazine on Harvard University’s George Church and developments in genomics, sequencing and synthetic biology.

A number of personalized genomics companies are mentioned in the article — some of whom are potential competitors, but not in our direct sales channel (yet) and some who are strictly in the personalized medicine space, not the personalized health space where we (Alticor/Amway/Quixtar) are positioned. Some of these include: 23andme, funded in part by Google; Navigenics, funded in part by Kleiner Perkins; DNA Direct, Sciona, Knome, and a few others.

 By the way, in case the inclusion of references to personal genomics and synthetic biology seems far fetched, they will in short order have a major impact on our area of business interest — Personalized Health and Wellness.

Finally, if the links above to Amway Wellness and Amway Beauty seem broken, it’s because at the time of this writing AmwayWellness is registered to Weber Shandwick, a consultancy which I’m surmising has been contracted by Alticor. And the AmwayBeauty domain is registered to Alticor through MarkMonitor.

This post is an addendum to my posts on Personalized Health on this site from June 23 and July 22, and Chuck Lia’s excellent posts from March 24 and May 1, this year.

Speaking of Chuck, he has just gotten back home to Atlanta from a few days in Southern California with his family.  Watch for a thought-provoking post from him later this week on … can’t tell you but it will be good!!!

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , , , , , , ,

Jul 29

A few days ago, Forbes Magazine published an article on former Quixtar IBO and TEAM co-founder Orrin Woodward that suggested Woodward’s training system business, now ported over to MonaVie, is little more than a thinly disguised “pyramid selling scheme.” The article, while not really critical of Amway per se, revealed a basic lack of understanding on the part of the Forbes reporters of direct sales business models which are legally and gainfully employing — many part time and some full time – millions of Americans and Canadians.

 In anticipation of the article’s publication, and after Forbes interviews with Alticor and Amway executives in Ada, Michigan, Amway sent a confidential communication out to all Diamonds and above, which was leaked by an astute and sympathetic Diamond (I’ve no clue who so don’t ask me) to the independent Amway commentary sites Amway Wiki, Amway Watch, Amway Talk, and The Truth About Amway.

In that letter, Amway executives promised,

We may object to aspects of these articles and will follow up with the publications regarding inaccuracies and misstatements … we remain committed to telling our own story and have invested an unprecedented amount in a national ad campaign, sponsorships, and public relations programs. Through these efforts, we will openly and transparently communicate who we are and what we stand for, creating greater awareness and favorability for our business opportunity and product brands – ultimately strengthening this business opportunity and the potential for success for every hard-working Independent Business Owner.

So, while the business and system critics were jumping up and down in their high chairs, spitting up, and throwing their food on the floor, what did Alticor do?

Alticor quietly purchased a significant volume of banner ads at Forbes.com, taking a positive upbeat approach with banner ad versions of the already familiar and popular ”Hello, my name is...” and “Now you know” ads which have been running so successfully in other media.

Was that a brilliant move or what!!!

SPEAKING OF AMWAY, what has Alticor learned from it’s PR battles of last year, and are they now performing in a much more transparent, proactive, and positive manner, consistent with the goals of the Transformation initiatives?

It’s a given that last year was a bumpy ride for Alticor PR particularly as they worked with green and “Internet-inexperienced” outside crisis management consultants who had no understanding of the community nature of and loyalty associated with our business model, to respond to a uniquely bitter legal attack by TEAM.

But has Alticor learned from that experience in the truest sense of being a Peter Senge ‘learning organization’?

I say ‘Yes’, in spades. What say ye?

written by rdknyvr \\ tags: , , , , , , , , , , , , , , ,